BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 31663464)

  • 1. Racial/Ethnic and Socioeconomic Disparities in Use of Direct-Acting Antivirals Among Medicare Beneficiaries with Chronic Hepatitis C, 2014-2016.
    Jung J; Du P; Feldman R; Kong L; Riley T
    J Manag Care Spec Pharm; 2019 Nov; 25(11):1236-1242. PubMed ID: 31663464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Racial-Ethnic Disparities in Uptake of New Hepatitis C Drugs in Medicare.
    Jung J; Feldman R
    J Racial Ethn Health Disparities; 2017 Dec; 4(6):1147-1158. PubMed ID: 27928769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disparities in Initiation of Direct-Acting Antiviral Agents for Hepatitis C Virus Infection in an Insured Population.
    Marcus JL; Hurley LB; Chamberland S; Champsi JH; Gittleman LC; Korn DG; Lai JB; Lam JO; Pauly MP; Quesenberry CP; Ready J; Saxena V; Seo SI; Witt DJ; Silverberg MJ
    Public Health Rep; 2018; 133(4):452-460. PubMed ID: 29750893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discontinuation of new hepatitis C drugs among Medicare patients.
    Jung J; Du P; Feldman R; Riley T
    Am J Manag Care; 2020 Feb; 26(2):84-88. PubMed ID: 32059096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health care utilization and costs associated with direct-acting antivirals for patients with substance use disorders and chronic hepatitis C.
    Jiang X; Vouri SM; Diaby V; Lo-Ciganic W; Parker R; Park H
    J Manag Care Spec Pharm; 2021 Oct; 27(10):1388-1402. PubMed ID: 34595949
    [No Abstract]   [Full Text] [Related]  

  • 6. Racial and Ethnic Disparities in Meeting MTM Eligibility Criteria Based on Star Ratings Compared with the Medicare Modernization Act.
    Spivey CA; Wang J; Qiao Y; Shih YT; Wan JY; Kuhle J; Dagogo-Jack S; Cushman WC; Chisholm-Burns M
    J Manag Care Spec Pharm; 2018 Feb; 24(2):97-107. PubMed ID: 29384031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding the Socioeconomic and Geographical Characteristics of Beneficiaries Receiving a Comprehensive Medication Review.
    Chou J; Pellegrin K; Cooke CE; Zarowitz B; Hanlon A; Lozano A; Brandt NJ
    J Manag Care Spec Pharm; 2020 Oct; 26(10):1276-1281. PubMed ID: 32996388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uptake of and Factors Associated With Direct-acting Antiviral Therapy Among Patients in the Chronic Hepatitis Cohort Study, 2014 to 2015.
    Spradling PR; Xing J; Rupp LB; Moorman AC; Gordon SC; Lu M; Teshale EH; Boscarino JA; Schmidt MA; Daida YG; Holmberg SD;
    J Clin Gastroenterol; 2018 Aug; 52(7):641-647. PubMed ID: 28590325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Race/ethnicity and insurance status disparities in access to direct acting antivirals for hepatitis C virus treatment.
    Wong RJ; Jain MK; Therapondos G; Shiffman ML; Kshirsagar O; Clark C; Thamer M
    Am J Gastroenterol; 2018 Sep; 113(9):1329-1338. PubMed ID: 29523864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Race and Gender Differences in the Use of Direct Acting Antiviral Agents for Hepatitis C Virus.
    Kanwal F; Kramer JR; El-Serag HB; Frayne S; Clark J; Cao Y; Taylor T; Smith D; White D; Asch SM
    Clin Infect Dis; 2016 Aug; 63(3):291-9. PubMed ID: 27131869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disparities in Access to Hepatitis C Treatment Among Arizona Medicaid Beneficiaries With Chronic Hepatitis C.
    Jiang X; Song HJ; Chang CY; Wilson D; Guo J; Lo-Ciganic WH; Park H
    Med Care; 2023 Feb; 61(2):81-86. PubMed ID: 36453625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can Telementoring Reduce Urban-Rural Disparities in Utilization of Direct-Acting Antiviral Agents?
    Du P; Wang X; Kong L; Jung J
    Telemed J E Health; 2021 May; 27(5):488-494. PubMed ID: 32882154
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of Direct-Acting Antiviral Agents and Survival Among Medicare Beneficiaries with Dementia and Chronic Hepatitis C.
    Tran L; Jung J; Carlin C; Lee S; Zhao C; Feldman R
    J Alzheimers Dis; 2021; 79(1):71-83. PubMed ID: 33216031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of direct-acting antivirals for chronic hepatitis C virus in the United States from a payer perspective.
    Kaplan DE; Serper M; Kaushik A; Durkin C; Raad A; El-Moustaid F; Smith N; Yehoshua A
    J Manag Care Spec Pharm; 2022 Oct; 28(10):1138-1148. PubMed ID: 36125059
    [No Abstract]   [Full Text] [Related]  

  • 15. Direct-Acting Antiviral Treatment Use Remains Low Among Florida Medicaid Beneficiaries With Chronic Hepatitis C.
    Park H; Song HJ; Jiang X; Henry L; Cook RL; Nelson DR
    Hepatol Commun; 2021 Feb; 5(2):203-216. PubMed ID: 33553969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short article: Alcohol and substance use, race, and insurance status predict nontreatment for hepatitis C virus in the era of direct acting antivirals: a retrospective study in a large urban tertiary center.
    Sims OT; Guo Y; Shoreibah MG; Venkata K; Fitzmorris P; Kommineni V; Romano J; Massoud OI
    Eur J Gastroenterol Hepatol; 2017 Nov; 29(11):1219-1222. PubMed ID: 28857899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eligibility Criteria for Lower Extremity Joint Replacement May Worsen Racial and Socioeconomic Disparities.
    Wang AY; Wong MS; Humbyrd CJ
    Clin Orthop Relat Res; 2018 Dec; 476(12):2301-2308. PubMed ID: 30303879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Racial Disparities in Readmission Rates among Patients Discharged to Skilled Nursing Facilities.
    Rivera-Hernandez M; Rahman M; Mor V; Trivedi AN
    J Am Geriatr Soc; 2019 Aug; 67(8):1672-1679. PubMed ID: 31066913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Did Medicare Part D reduce disparities?
    Zissimopoulos J; Joyce GF; Scarpati LM; Goldman DP
    Am J Manag Care; 2015 Feb; 21(2):119-28. PubMed ID: 25880361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shift in disparities in hepatitis C treatment from interferon to DAA era: A population-based cohort study.
    Janjua NZ; Islam N; Wong J; Yoshida EM; Ramji A; Samji H; Butt ZA; Chong M; Cook D; Alvarez M; Darvishian M; Tyndall M; Krajden M
    J Viral Hepat; 2017 Aug; 24(8):624-630. PubMed ID: 28130810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.